NLSP - NLS Pharmaceutics AG - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

NLS Pharmaceutics AG's activity chart (see below) currently has 3 price targets and 5 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 66.67% of the time, taking 678 days on average.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 14-Sep-2023. First documented stock forecast 12-Mar-2021.

Best performing analysts who are covering NLSP - NLS Pharmaceutics AG:

Jason Mccarthy Kumaraguru Raja Yale Jen

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 14-Sep-2023

$160

3 years 2 months 7 days ago
(14-Sep-2023)

1/1 (100%)

$-204.08 (-56.05%)

343

Buy Since 06-Sep-2022

$6

4 years 2 months 15 days ago
(06-Sep-2022)

0/1 (0%)

$-234.04 (-97.50%)

Buy Since 12-Mar-2021

$12

5 years 8 months 9 days ago
(12-Mar-2021)

1/1 (100%)

$-2328 (-99.49%)

1691

Show more analysts

Please expand the browser size to see the chart

What is NLSP (NLS Pharmaceutics AG) average time for price targets to be met?

On average it took 678 days for the stock forecasts to be reached, with an average price target met ratio of 66.67%.

Which analyst most recently updated their price target on NLSP (NLS Pharmaceutics AG)?

Jason Mccarthy

Which analyst has the lowest performance score on NLSP (NLS Pharmaceutics AG) with a proven track record?

YALE JEN

Which analyst has the most public recommendations on NLSP (NLS Pharmaceutics AG)?

Jason Mccarthy works at MAXIM GROUP and has 3 price targets and 3 ratings on NLSP

Which analyst is the currently most bullish on NLSP (NLS Pharmaceutics AG)?

Kumaraguru Raja with the highest potential upside of $4.38

Which analyst is the currently most reserved on NLSP (NLS Pharmaceutics AG)?

Yale Jen with the lowest potential downside of -$1.62
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?